MEDIFAST INC·4

May 8, 7:03 PM ET

MACDONALD MICHAEL C 4

4 · MEDIFAST INC · Filed May 8, 2020

Insider Transaction Report

Form 4
Period: 2020-01-02
Transactions
  • Sale

    Common Stock

    2020-01-02$110.52/sh500$55,260283,956 total
  • Sale

    Common Stock

    2020-01-02$111.62/sh2,412$269,227281,544 total
  • Sale

    Common Stock

    2020-01-02$112.31/sh1,448$162,625280,096 total
  • Sale

    Common Stock

    2020-01-02$109.40/sh640$70,016284,456 total
  • Sale

    Common Stock

    2020-05-06$90.35/sh3,200$289,120276,896 total
  • Sale

    Common Stock

    2020-05-06$91.42/sh1,800$164,556275,096 total
Footnotes (7)
  • [F1]The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.12 to $109.99, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.21 to $110.79, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.96, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.02 to $112.83, inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.98, inclusive.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $92.00, inclusive.

Documents

1 file
  • 4
    tm2019159d2_4.xmlPrimary

    OWNERSHIP DOCUMENT